Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wataru Obara

Showing results (91-100 of 170) with videos related to

Pageof 17
Sort By:
Cancer Science|May 13, 2017
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancerWataru Obara, Fuminori Sato, Kazuyoshi Takeda, et al.
IJU Case Reports|March 5, 2024
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysisEi Shiomi, Yuta Goto, Mizuki Hisano, et al.
International Journal of Clinical Oncology|January 8, 2020
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practiceDaichi Tamura, Noriaki Jinnouchi, Masakazu Abe, et al.
Plos One|December 17, 2025
The evaluation of indoxyl sulfate in the general population in Kanegasaki Iwate: A cross-sectional study (KANEGASAKI study)Mizuki Hisano, Takaya Abe, Kie Sekiguchi, et al.
Translational Oncology|October 31, 2020
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancerRenpei Kato, Noriaki Jinnouchi, Takashi Tuyukubo, et al.
International Journal of Clinical and Experimental Pathology|January 15, 2020
Sarcomatoid change associated with epithelial-mesenchymal transition in mucinous tubular and spindle cell carcinoma of the kidney: a case reportRyo Sugimoto, Noriyuki Uesugi, Noriyuki Yamada, et al.
IJU Case Reports|May 12, 2021
Relationship between miR-155 expression and clear cell papillary renal cell carcinoma in the dialyzed kidneyEi Shiomi, Renpei Kato, Tomohiko Matsuura, et al.
Cancer Immunology, Immunotherapy : CII|October 21, 2016
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinomaWataru Obara, Takashi Karashima, Kazuyoshi Takeda, et al.
Pharmacogenomics|February 5, 2008
Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patientsKenji Nakai, Jyunichi Tsuboi, Hitoshi Okabayashi, et al.
Journal of Radiation Research|May 15, 2023
Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry databaseMasayuki Araya, Hitoshi Ishikawa, Kentaro Nishioka, et al.
Pageof 17

Showing results (91-100 of 170) with videos related to

Sort By:
Pageof 17
Cancer Science|May 13, 2017
Phase I clinical trial of cell division associated 1 (CDCA1) peptide vaccination for castration resistant prostate cancerWataru Obara, Fuminori Sato, Kazuyoshi Takeda, et al.
IJU Case Reports|March 5, 2024
A case of complete response to avelumab plus axitinib combination therapy for metastatic clear cell renal cell carcinoma in a kidney undergoing dialysisEi Shiomi, Yuta Goto, Mizuki Hisano, et al.
International Journal of Clinical Oncology|January 8, 2020
Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practiceDaichi Tamura, Noriaki Jinnouchi, Masakazu Abe, et al.
Plos One|December 17, 2025
The evaluation of indoxyl sulfate in the general population in Kanegasaki Iwate: A cross-sectional study (KANEGASAKI study)Mizuki Hisano, Takaya Abe, Kie Sekiguchi, et al.
Translational Oncology|October 31, 2020
TIM3 expression on tumor cells predicts response to anti-PD-1 therapy for renal cancerRenpei Kato, Noriaki Jinnouchi, Takashi Tuyukubo, et al.
International Journal of Clinical and Experimental Pathology|January 15, 2020
Sarcomatoid change associated with epithelial-mesenchymal transition in mucinous tubular and spindle cell carcinoma of the kidney: a case reportRyo Sugimoto, Noriyuki Uesugi, Noriyuki Yamada, et al.
IJU Case Reports|May 12, 2021
Relationship between miR-155 expression and clear cell papillary renal cell carcinoma in the dialyzed kidneyEi Shiomi, Renpei Kato, Tomohiko Matsuura, et al.
Cancer Immunology, Immunotherapy : CII|October 21, 2016
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinomaWataru Obara, Takashi Karashima, Kazuyoshi Takeda, et al.
Pharmacogenomics|February 5, 2008
Ethnic differences in the VKORC1 gene polymorphism and an association with warfarin dosage requirements in cardiovascular surgery patientsKenji Nakai, Jyunichi Tsuboi, Hitoshi Okabayashi, et al.
Journal of Radiation Research|May 15, 2023
Proton beam therapy for muscle-invasive bladder cancer: A systematic review and analysis with Proton-Net, a multicenter prospective patient registry databaseMasayuki Araya, Hitoshi Ishikawa, Kentaro Nishioka, et al.
Pageof 17